Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

FBIOP Fortress Biotech Inc

7,08

0,08 (1,14%)

Zuletzt aktualisiert: 19:22:47

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Fortress Biotech (NASDAQ:FBIOP)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Fortress Biotech Charts.

Fortress Biotech (NASDAQ:FBIOP)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Fortress Biotech Charts.

News Fortress Biotech Inc

Form 8-K - Current report
Donnerstag 16 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 6 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease
Montag 6 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Samstag 4 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 16 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
Donnerstag 14 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 4 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 25 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dienstag 1 Oktober 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Fortress Biotech Inc News-Artikel

NGM Biopharmaceuticals

Quaker Houghton

International Bank for R...

Leonteq Securities

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen